This prevalence was 1.8% (112/6192) in 2015 and 4.2% (230/5500) in 2022, indicating an increasing trend over time.
← all excerpts
Verification of the increase in concomitant dysplasia and cancer with the size of sessile serrated lesions.
1
—
—
This prevalence was 1.8% (112/6192) in 2015 and 4.2% (230/5500) in 2022, indicating an increasing trend over time.